Landon D Hughes1, Kacie M Kidd2, Kristi E Gamarel3, Don Operario4, Nadia Dowshen5. 1. Department of Health Behavior and Health Education, University of Michigan School of Public Health, Ann Arbor, Michigan; Institute for Social Research, University of Michigan, Ann Arbor, Michigan. Electronic address: landonh@umich.edu. 2. Department of Pediatrics, West Virginia University School of Medicine, 1 Medical Center Dr, Morgantown, West Virginia. 3. Department of Health Behavior and Health Education, University of Michigan School of Public Health, Ann Arbor, Michigan; Institute for Social Research, University of Michigan, Ann Arbor, Michigan. 4. Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, Rhode Island. 5. Colonial Penn Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.
Abstract
PURPOSE: The standards of care for transgender and gender diverse youth (TGDY) experiencing gender dysphoria are well-established and include gender-affirming medical interventions. As of July 2021, 22 states have introduced or passed legislation that bans the provision of gender-affirming medical care to anyone under the age of 18 even with parent or guardian consent. The purpose of this study is to understand what providers who deliver gender-affirming medical care to TGDY think about this legislation. METHODS: In March 2021, we recruited participants via listservs known to be frequented by providers of gender-affirming medical care. Eligible participants were over the age of 18, currently working as a physician, nurse practitioner, or physician's assistant, and providing gender-affirming care to TGDY under the age of 18 in the U.S. RESULTS: We analyzed the responses of 103 providers from all 50 states and DC. Most participants identified as white (77%), cisgender women (70%), specializing in pediatric care (52%). The most salient theme, described by nearly all participants, was the fear that legislation banning gender-affirming care would lead to worsening mental health including increased risk for suicides among TGDY. Other themes included the politicization of medical care, legislation that defies the current standards of care for TGDY, worsening discrimination toward TGDY, and adverse effects on the providers. CONCLUSIONS: Providers of gender-affirming care overwhelmingly opposed legislation that bans gender-affirming care for TGDY citing the severe consequences to the health and well-being of TGDY along with the need to practice evidence-based medicine without fear.
PURPOSE: The standards of care for transgender and gender diverse youth (TGDY) experiencing gender dysphoria are well-established and include gender-affirming medical interventions. As of July 2021, 22 states have introduced or passed legislation that bans the provision of gender-affirming medical care to anyone under the age of 18 even with parent or guardian consent. The purpose of this study is to understand what providers who deliver gender-affirming medical care to TGDY think about this legislation. METHODS: In March 2021, we recruited participants via listservs known to be frequented by providers of gender-affirming medical care. Eligible participants were over the age of 18, currently working as a physician, nurse practitioner, or physician's assistant, and providing gender-affirming care to TGDY under the age of 18 in the U.S. RESULTS: We analyzed the responses of 103 providers from all 50 states and DC. Most participants identified as white (77%), cisgender women (70%), specializing in pediatric care (52%). The most salient theme, described by nearly all participants, was the fear that legislation banning gender-affirming care would lead to worsening mental health including increased risk for suicides among TGDY. Other themes included the politicization of medical care, legislation that defies the current standards of care for TGDY, worsening discrimination toward TGDY, and adverse effects on the providers. CONCLUSIONS: Providers of gender-affirming care overwhelmingly opposed legislation that bans gender-affirming care for TGDY citing the severe consequences to the health and well-being of TGDY along with the need to practice evidence-based medicine without fear.
Authors: Annelou L C de Vries; Thomas D Steensma; Theo A H Doreleijers; Peggy T Cohen-Kettenis Journal: J Sex Med Date: 2010-07-14 Impact factor: 3.802
Authors: Annelou L C de Vries; Jenifer K McGuire; Thomas D Steensma; Eva C F Wagenaar; Theo A H Doreleijers; Peggy T Cohen-Kettenis Journal: Pediatrics Date: 2014-09-08 Impact factor: 7.124
Authors: Wylie C Hembree; Peggy T Cohen-Kettenis; Louis Gooren; Sabine E Hannema; Walter J Meyer; M Hassan Murad; Stephen M Rosenthal; Joshua D Safer; Vin Tangpricha; Guy G T'Sjoen Journal: J Clin Endocrinol Metab Date: 2017-11-01 Impact factor: 5.958
Authors: Landon D Hughes; Nadia Dowshen; Kacie M Kidd; Don Operario; Christopher Renjilian; Kristi E Gamarel Journal: LGBT Health Date: 2022-04-01 Impact factor: 5.150
Authors: Megan E Gandy; Kacie M Kidd; James Weiss; Judith Leitch; Xavier Hersom Journal: Int J Environ Res Public Health Date: 2021-12-02 Impact factor: 3.390